Cargando…

What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

BACKGROUND: Neoadjuvant therapy with dual HER2 blockade improved pathological complete response (pCR) rate in HER2‐positive breast cancer patients. Nevertheless, it would be desirable to identify patients exquisitely responsive to single agent trastuzumab to minimize or avoid overtreatment. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pizzamiglio, Sara, Cosentino, Giulia, Ciniselli, Chiara M., De Cecco, Loris, Cataldo, Alessandra, Plantamura, Ilaria, Triulzi, Tiziana, El‐abed, Sarra, Wang, Yingbo, Bajji, Mohammed, Nuciforo, Paolo, Huober, Jens, Ellard, Susan L., Rimm, David L., Gombos, Andrea, Daidone, Maria Grazia, Verderio, Paolo, Tagliabue, Elda, Di Cosimo, Serena, Iorio, Marilena V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729061/ https://www.ncbi.nlm.nih.gov/pubmed/34921525 http://dx.doi.org/10.1002/cam4.4449

Ejemplares similares

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials
por: Chumsri, Saranya, et al.
Publicado: (2022)

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials
por: Rediti, Mattia, et al.
Publicado: (2023)

An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)
por: Risi, Emanuela, et al.
Publicado: (2019)

Developing miRNA signatures: a multivariate prospective
por: Verderio, Paolo, et al.
Publicado: (2016)

Data and performances evaluation of the SPIDIA-DNA Pan-European External Quality Assessment: 2nd SPIDIA-DNA laboratory report
por: Malentacchi, Francesca, et al.
Publicado: (2016)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center
por: Ciniselli, Chiara Maura, et al.
Publicado: (2022)

Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
por: Fina, Emanuela, et al.
Publicado: (2017)

Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
por: Cosentino, Giulia, et al.
Publicado: (2021)

Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host
por: Di Modica, Martina, et al.
Publicado: (2017)

Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
por: Fina, Emanuela, et al.
Publicado: (2022)

Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors
por: Giussani, Marta, et al.
Publicado: (2019)

Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences
por: Rybinska, Ilona, et al.
Publicado: (2021)

Peritoneal fluid COVID-19 testing in patients with a negative nasopharyngeal swab: prospective study
por: Licata, Armando G, et al.
Publicado: (2023)

FCI: an R-based algorithm for evaluating uncertainty of absolute real-time PCR quantification
por: Verderio, Paolo, et al.
Publicado: (2008)

SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region
por: Ciniselli, Chiara Maura, et al.
Publicado: (2021)

Adipocytes in Breast Cancer, the Thick and the Thin
por: Rybinska, Ilona, et al.
Publicado: (2020)

3Rs Principle and Legislative Decrees to Achieve High Standard of Animal Research
por: Verderio, Paolo, et al.
Publicado: (2023)

The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
por: Di Modica, Martina, et al.
Publicado: (2022)

Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data
por: Sala, Laura, et al.
Publicado: (2022)

Correction: Effects of Warm Ischemic Time on Gene Expression Profiling in Colorectal Cancer Tissues and Normal Mucosa
por: Musella, Valeria, et al.
Publicado: (2013)

Effects of Warm Ischemic Time on Gene Expression Profiling in Colorectal Cancer Tissues and Normal Mucosa
por: Musella, Valeria, et al.
Publicado: (2013)

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer
por: Cataldo, Alessandra, et al.
Publicado: (2020)

Biomarkers for Monitoring Pre-Analytical Quality Variation of mRNA in Blood Samples
por: Zhang, Hui, et al.
Publicado: (2014)

SPIDIA-RNA: Second External Quality Assessment for the Pre-Analytical Phase of Blood Samples Used for RNA Based Analyses
por: Malentacchi, Francesca, et al.
Publicado: (2014)

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective
por: Fogazzi, Valentina, et al.
Publicado: (2022)

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
por: Lucci, Maria Antonietta, et al.
Publicado: (2010)

Infrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer
por: Tiwari, Saumya, et al.
Publicado: (2020)

Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread
por: Spreafico, Filippo, et al.
Publicado: (2017)

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases
por: Le Noci, Valentino, et al.
Publicado: (2019)

Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
por: Giussani, Marta, et al.
Publicado: (2021)

Multiparametric Analysis of Cell-Free DNA in Melanoma Patients
por: Salvianti, Francesca, et al.
Publicado: (2012)

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial
por: Triulzi, Tiziana, et al.
Publicado: (2021)

NEO E-vita—NEO era!
por: Jakob, Heinz, et al.
Publicado: (2022)

Written Prescriptions
Publicado: (1867)

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial
por: Lambertini, Matteo, et al.
Publicado: (2020)

Nahuatl as written : lessons in older written Nahuatl, with copious examples and texts /
por: Lockhart, James
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_cdvrs5q9f25qud707iuc8ih7p0